Abstract:Background: Paclitaxel is a natural anticancer drug, which has demonstrated significant activity in clinical trials. However, it has been limited due to poor aqueous solubility. Chitosan can be modified into graft copolymer, which changed into nanoparticles in aqueous solution, and employed as controlled release carriers for drugs. Objective: To study the characterization, in addition, to evaluate in vitro drug release ability of paclitaxel nanoparticles. Design, time and setting: A repeated measurement design was conducted at the Laboratory of North China Coal Medical University from January 2008 to July 2008. Materials: The average molecular weight of 2.0 × 10 5 chitosan with 92% deacetylation degree was produced by Golden-shell Biochemical Co., Ltd. Paclitaxel (lot number: 082329802) was provided by National Institute for the Control of Pharmaceutical and Biological Products. Methods: The potassium diperiodaton-ickelate served as initiator, chitosan-graft-vinyl acetate copolymers were synthesized by free radical graft copolymerization, which could be directly transformed into nanoparticles with hydrophobic core and hydrophilic surface in the water medium. Paclitaxel nanopartioles were prepared via mixture 0.5-5.0 mg paclitaxel with nanoparticles by ultrasonic irradiation technology. Main outcome measures: Particles size, polydispersity index zeta potential was detected by laser particle size analyzer. The morphology of chitosan nanoparticles and paclitaxel nanoparticles was observed by transmission electron microscope. In addition, encapsulation capability, loading content and in vitro drug release of the paclitaxel nanoparticles was analyzed by high-performance liquid chromatography. Results: The mean diameters of chitosan nanoparticles and paclitaxel nanoparticles were 196.2 nm and 320.8 nm, respectively. The nanoparticles possessed a uniform particles size distribution and an obvious positive charge surface, but the Zeta potential had no significant difference (F=0.818, F=3.38, all P > 0.05). The dose of paclitaxel could affect the encapsulation rate, which could up to 93.6% when added the quantity of paclitaxel was 2% of anoparticles. The results of simulate drug release showed that drug release was reach 48.3% in 24 hours at the burst release phase, which up to 75.9% at 175 hours longer in the slower release phase. The encapsulation rate of drug-loaded nanoparticles was stable. Conclusion: The preparation method is reliable and simple. The nanoparticles possessed good physical performance and sustained release character in vitro.

Controlled drug release capability of paclitaxel-loaded poly(butylcyanoacrylate)-pluronic P123/F68 polymeric micells

Study on the Preparation of Paclitaxel-Loaded Pluronic Stabilized Micellae

Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micelles

Pharmacokinetics and Biodistribution of Polymeric Micelles of Paclitaxel with Pluronic P105/poly(caprolactone) Copolymers.

Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105/L101 mixed polymeric micelles.

Pharmacokinetics and Biodistribution of Polymeric Micelles of Paclitaxel with Pluronic P123

Paclitaxel-Loaded Pluronic P123/F127 Mixed Polymeric Micelles: Formulation, Optimization and in Vitro Characterization

Preparation, characterization and drug release property of paclitaxel nanoparticles

Functionalized Pluronic-b-poly(ε-caprolactone) based nanocarriers of paclitaxel: solubilization, antiproliferative efficacy and in vivo pharmaceutic kinetics.

Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.

Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance

IN VITRO RELEASE KINETICS OF AMPHIPHILIC BLOCK COPOLYMER NANO-MICELLES LOADED WITH PACLITAXEL

A new water-soluble nano-micelle formulation of paclitaxel loaded in amphiphilic block copolymer

Pluronic-poly (acrylic acid)-cysteine/Pluronic L121 mixed micelles improve the oral bioavailability of paclitaxel

Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiation

Preparation and Characterization of Poly(lactic Acid)–poly(ethylene Glycol)–poly(lactic Acid) (PLA–PEG–PLA) Microspheres for Controlled Release of Paclitaxel

Effects of Polymer Terminal Group Inside Micelle Core on Paclitaxel Loading Promoting and Burst Release Suppressing

Characterization and biological evaluation of paclitaxel-loaded poly(L-lactic acid) microparticles prepared by supercritical CO2.

Synthesis, characterization, and application of amino-terminated poly(ethylene glycol)-block-poly(ε-caprolactone) copolymer for paclitaxel

Synthesis and Characterization of Paclitaxel-Imprinted Microparticles for Controlled Release of an Anticancer Drug.

Novel Biodegradable Polylactide/poly(ethylene glycol) Micelles Prepared by Direct Dissolution Method for Controlled Delivery of Anticancer Drugs